Rioux Benjamin, Pouget Christelle, Fidanzi-Dugas Chloë, Gamond Aurélie, Laurent Aurélie, Semaan Josiane, Pinon Aline, Champavier Yves, Léger David Y, Liagre Bertrand, Duroux Jean-Luc, Fagnère Catherine, Sol Vincent
Université de Limoges, Laboratoire de Chimie des Substances Naturelles, EA 1069, F-87000 Limoges, France.
Université de Limoges, BISCEm, F-87000 Limoges, France.
Bioorg Med Chem Lett. 2017 Sep 15;27(18):4354-4357. doi: 10.1016/j.bmcl.2017.08.024. Epub 2017 Aug 13.
The aim of this study is to synthesize chalcone-polyamine conjugates in order to enhance bioavailability and selectivity of chalcone core towards cancer cells, using polyamine-based vectors. 3-hydroxy-3',4,4',5'-tetramethoxychalcone (1) and 3',4,4',5'-tetramethoxychalcone (2) were selected as parent chalcones since they were found to be efficient anti-proliferative agents on various cancer cells. A series of ten chalcone-polyamine conjugates was obtained by reacting carboxychalcones with different polyamine tails. Chalcones 1 and 2 showed a strong cytotoxic activity against two prostatic cancer (PC-3 and DU-145) and two colorectal cancer (HT-29 and HCT-116) cell lines. Then, chalcone-spermine conjugates 7d and 8d were shown to be the most active of the series and could be considered as promising compounds for colon and prostatic cancer adjuvant therapy.
本研究的目的是使用基于多胺的载体合成查尔酮 - 多胺共轭物,以提高查尔酮核心对癌细胞的生物利用度和选择性。选择3 - 羟基 - 3',4,4',5'-四甲氧基查尔酮(1)和3',4,4',5'-四甲氧基查尔酮(2)作为母体查尔酮,因为它们被发现对各种癌细胞是有效的抗增殖剂。通过使羧基查尔酮与不同的多胺尾部反应,获得了一系列十种查尔酮 - 多胺共轭物。查尔酮1和2对两种前列腺癌(PC - 3和DU - 145)和两种结肠直肠癌(HT - 29和HCT - 116)细胞系表现出强烈的细胞毒性活性。然后,查尔酮 - 精胺共轭物7d和8d被证明是该系列中最具活性的,可被视为用于结肠癌和前列腺癌辅助治疗的有前景的化合物。